afdx 384 has been researched along with dimethindene in 1 studies
| Studies (afdx 384) | Trials (afdx 384) | Recent Studies (post-2010) (afdx 384) | Studies (dimethindene) | Trials (dimethindene) | Recent Studies (post-2010) (dimethindene) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 212 | 50 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böhme, TM; Dannhardt, G; Keim, C; Lambrecht, G; Mutschler, E | 1 |
1 other study(ies) available for afdx 384 and dimethindene
| Article | Year |
|---|---|
Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.
Topics: Alzheimer Disease; Humans; In Vitro Techniques; Ligands; Quinuclidines; Radiopharmaceuticals; Receptor, Muscarinic M2; Receptors, Muscarinic; Tomography, Emission-Computed | 2001 |